Kamada Ltd KMDA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $7.15
- Day Range
- $7.07–7.11
- 52-Week Range
- $6.54–9.32
- Bid/Ask
- $0.00 / $0.00
- Shares Outstanding
- 57.69M
- Market Cap
- $410.78M
- Volume/Avg
- 10,238 / 44,626
Key Statistics
- Price/Earnings (Normalized)
- 20.12
- Price/Sales
- 2.34
- Dividend Yield (Trailing)
- 3.51%
- Dividend Yield (Forward)
- 3.51%
- Total Yield
- 3.51%
Company Profile
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 462
- Website
- https://www.kamada.com
Valuation
|
Metric
|
KMDA
|
|---|---|
Price/Earnings (Normalized) | 20.12 |
Price/Book Value | 1.67 |
Price/Sales | 2.34 |
Price/Cash Flow | 9.86 |
Price/Earnings
KMDA
Financial Strength
|
Metric
|
KMDA
|
|---|---|
Quick Ratio | 1.90 |
Current Ratio | 3.33 |
Interest Coverage | 24.76 |
Quick Ratio
KMDA
Profitability
|
Metric
|
KMDA
|
|---|---|
Return on Assets (Normalized) | 6.70% |
Return on Equity (Normalized) | 9.87% |
Return on Invested Capital (Normalized) | 8.93% |
Return on Assets
KMDA
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|xw@$h#< | LOCK|lhNP@ | $69B | |||
| Haleon PLC ADR
HLN
| LOCK|pjG@H%$ | LOCK|LB< | $43B | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| LOCK|wn@q<$B | LOCK|BM!>> | $38B | |||
| Zoetis Inc Class A
ZTS
| LOCK|?HNDHjVY | LOCK|!&> | $32B | |||
| Viatris Inc
VTRS
| LOCK|<Vkq&M | LOCK|q>C | $19B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|?@$ | LOCK|#W^ | $12B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|tWtK># | LOCK|S<& | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|Cr^Hz^ | LOCK|wv | $8B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|Dy?BJ< | LOCK|?nSGd | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|F#bLPCR | LOCK|Zy< | $1B |
United States